A profile of volatile organic compounds in breath discriminates COPD patients from controls
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 104 (4), 557-563
- https://doi.org/10.1016/j.rmed.2009.10.018
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled airJournal of Chromatography B, 2008
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- Volatile biomarkers of pulmonary tuberculosis in the breathTuberculosis, 2007
- Diagnostic potential of breath analysis—focus on volatile organic compoundsClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Exhaled markers of inflammationCurrent Opinion in Allergy and Clinical Immunology, 2001
- Current and future medical costs of asthma and chronic obstructive pulmonary disease in the NetherlandsRespiratory Medicine, 1999
- Volatile organic compounds in breath as markers of lung cancer: a cross-sectional studyThe Lancet, 1999
- Exhaled carbon monoxide levels during treatment of acute asthmaEuropean Respiratory Journal, 1999
- Optimization and testing of mass spectral library search algorithms for compound identificationJournal of the American Society for Mass Spectrometry, 1994
- Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition ChromatographyProceedings of the National Academy of Sciences of the United States of America, 1971